Abstract
We investigated the activity of a pyrazolo-isothiazole derivative (G8) against Cryptococcus neoformans. A first screening test showed that G8 at 10 mg/L inhibited the growth of 14 of 15 clinical isolates tested. Killing experiments showed that fungicidal activity was achieved after 8 h of treatment with G8 at concentrations ≥10 mg/L. In a murine model of systemic cryptococcosis, G8 was effective at prolonging survival compared with the controls. Our data indicate that this new derivative has a potential therapeutic role in infections caused by C. neoformans.
Lingua originale | English |
---|---|
pagine (da-a) | 167-170 |
Numero di pagine | 4 |
Rivista | Journal of Antimicrobial Chemotherapy |
Volume | 51 |
Stato di pubblicazione | Published - 2003 |
All Science Journal Classification (ASJC) codes
- ???subjectarea.asjc.3000.3004???
- ???subjectarea.asjc.2700.2726???
- ???subjectarea.asjc.2700.2736???
- ???subjectarea.asjc.2700.2725???